The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke

References

• Feigin V, Forouzanfar M, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245–254. doi:10.1016/s0140-6736(13)61953-4
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480,687 adults. Circulation. 2017;135(8):759–771. doi:10.1161/circulationaha.116.025250
   PubMed Web of Science ®Google Scholar
• Hotter B, Hoffmann S, Ulm L, et al. External validation of five scores to predict stroke-associated pneumonia and the role of selected blood biomarkers. Stroke. 2021;52(1):325–330. doi:10.1161/strokeaha.120.031884
   PubMed Web of Science ®Google Scholar
• Nam K, Kim T, Lee J, et al. High neutrophil-to-lymphocyte ratio predicts stroke-associated pneumonia. Stroke. 2018;49(8):1886–1892. doi:10.1161/strokeaha.118.021228
   PubMed Web of Science ®Google Scholar
• Ji R, Shen H, Pan Y, et al. Novel risk score to predict pneumonia after acute ischemic stroke. Stroke. 2013;44(5):1303–1309. doi:10.1161/strokeaha.111.000598
   PubMed Web of Science ®Google Scholar
• Gong P, Liu Y, Gong Y, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. J Neuroinflammation. 2021;18(1):51. doi:10.1186/s12974-021-02090-6
   PubMed Web of Science ®Google Scholar
• Lambertsen KL, Finsen B, Clausen BH. Post-stroke inflammation—target or tool for therapy? Acta Neuropathol. 2018;137(5):693–714. doi:10.1007/s00401-018-1930-z
   PubMed Web of Science ®Google Scholar
• Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5(1):201. doi:10.1038/s41392-020-00303-7
   PubMed Web of Science ®Google Scholar
• Yeo I, Lee C, Han S, Yun J, Hong J. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacol Ther. 2019;203:107394. doi:10.1016/j.pharmthera.2019.107394
   PubMed Web of Science ®Google Scholar
• Park H, Jun C, Jeon S, et al. Serum YKL-40 levels correlate with infarct volume, stroke severity, and functional outcome in acute ischemic stroke patients. PLoS One. 2012;7(12):e51722. doi:10.1371/journal.pone.0051722
   PubMed Web of Science ®Google Scholar
• Lad S, Hegen H, Gupta G, Deisenhammer F, Steinberg G. Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2012;21(1):30–41. doi:10.1016/j.jstrokecerebrovasdis.2010.04.004
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhang G, Wang Z, Yang H. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage. Clin Biochem. 2014;47(18):302–306. doi:10.1016/j.clinbiochem.2014.09.015
   PubMed Web of Science ®Google Scholar
• Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.str.24.1.35
   PubMed Web of Science ®Google Scholar
• Smith CJ, Kishore AK, Vail A, et al. Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group. Stroke. 2015;46(8):2335–2340. doi:10.1161/strokeaha.115.009617
   PubMed Web of Science ®Google Scholar
• Shi G, Li M, Zhou R, et al. Procalcitonin related to stroke-associated pneumonia and clinical outcomes of acute ischemic stroke after IV rt-PA treatment. Cell Mol Neurobiol. 2021;1–9. doi:10.1007/s10571-020-01031-w
   Web of Science ®Google Scholar
• Deng Q, Gong P, Chen X, et al. Admission blood cell counts are predictive of stroke-associated infection in acute ischemic stroke patients treated with endovascular therapy. Neurol Sci. 2021;42(6):2397–2409. doi:10.1007/s10072-020-04827-2
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu Y, Han L, et al. Risk factors for acute stroke-associated pneumonia and prediction of neutrophil-to-lymphocyte ratios. Am J Emerg Med. 2021;41:55–59. doi:10.1016/j.ajem.2020.12.036
   PubMed Web of Science ®Google Scholar
• Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058–1066. doi:10.1016/s1474-4422(19)30078-x
   PubMed Web of Science ®Google Scholar
• Tong X, Wang D, Liu S, et al. The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:409–418. doi:10.2147/copd.s152655
   PubMed Web of Science ®Google Scholar
• Kjaergaard A, Helby J, Johansen J, Nordestgaard B, Bojesen S. Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population. Clin Microbiol Infect. 2020;26(10):1411.e1411–1411.e1419. doi:10.1016/j.cmi.2020.01.010
   PubMed Web of Science ®Google Scholar
• Spoorenberg S, Vestjens S, Rijkers G, et al. YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia. Respirology. 2017;22(3):542–550. doi:10.1111/resp.12924
   PubMed Web of Science ®Google Scholar
• Pala S, Sari M, Kahveci G, Alizade E, Arslantas U, Uslu A. Plasma YKL-40 elevation on admission and follow-up is associated with diastolic dysfunction and mortality in patients with acute myocardial infarction. Cardiol Res Pract. 2018;2018:8701851. doi:10.1155/2018/8701851
   PubMed Web of Science ®Google Scholar
• Chen X, Li Q, Huang W, et al. Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke. Acta Neurol Scand. 2017;136(2):97–102. doi:10.1111/ane.12688
   PubMed Web of Science ®Google Scholar
• Yasuda T, Kaneto H, Katakami N, et al. YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients. Diabetes Res Clin Pract. 2011;91(2):e50–e52. doi:10.1016/j.diabres.2010.11.015
   PubMed Web of Science ®Google Scholar
• Clausen B, Lambertsen K, Babcock A, Holm T, Dagnaes-Hansen F, Finsen B. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation. 2008;5:46. doi:10.1186/1742-2094-5-46
   PubMed Web of Science ®Google Scholar
• Downes C, Crack P. Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? Br J Pharmacol. 2010;160(8):1872–1888. doi:10.1111/j.1476-5381.2010.00864.x
   PubMed Web of Science ®Google Scholar
• Kim MJ, Shim DH, Cha HR, et al. Chitinase 3-like 1 protein plays a critical role in respiratory syncytial virus-induced airway inflammation. Allergy. 2018;74(4):685–697. doi:10.1111/all.13661
   PubMed Web of Science ®Google Scholar
• Im JH, Yeo IJ, Park PH, et al. Deletion of Chitinase-3-like 1 accelerates stroke development through enhancement of Neuroinflammation by STAT6-dependent M2 microglial inactivation in Chitinase-3-like 1 knockout mice. Exp Neurol. 2020;323:113082. doi:10.1016/j.expneurol.2019.113082
   PubMed Web of Science ®Google Scholar
• Li J, Feng L, Huang Q, Ren W. An L-shaped relationship between serum iron and stroke-associated pneumonia. Clin Interv Aging. 2021;16:505–511. doi:10.2147/cia.s301480
   PubMed Web of Science ®Google Scholar
• Gradek-Kwinta E, Czyzycki M, Lopatkiewicz A, Klimiec-Moskal E, Slowik A, Dziedzic T. Lipopolysaccharide binding protein and sCD14 as risk markers of stroke-associated pneumonia. J Neuroimmunol. 2021;354:577532. doi:10.1016/j.jneuroim.2021.577532
   PubMed Web of Science ®Google Scholar
• Hoffmann S, Harms H, Ulm L, et al. Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia - the PREDICT study. J Cereb Blood Flow Metab. 2017;37(12):3671–3682. doi:10.1177/0271678x16671964
   PubMed Web of Science ®Google Scholar
• Faura J, Bustamante A, Miró-Mur F, Montaner J. Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections. J Neuroinflammation. 2021;18(1):127. doi:10.1186/s12974-021-02177-0
   PubMed Web of Science ®Google Scholar